Aurobindo Biotech Products Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 2.00 Cr
as on 23-10-2024
- Company Age 26 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.10 Cr
as on 23-10-2024
- Revenue %
(FY 2023)
- Profit 15.87%
(FY 2023)
- Ebitda
- Net Worth -0.29%
(FY 2023)
- Total Assets -0.00%
(FY 2023)
About Aurobindo Biotech Products
The Corporate was formerly known as A.B. Switch Gear (India) Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹12.10 Cr.
Mancham Chandrabose and Sreeram Manchem serve as directors at the Company.
- CIN/LLPIN
U29309TN1998PTC040578
- Company No.
040578
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aurobindo Biotech Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreeram Manchem  | Director | 29-May-1998 | Current |
| Mancham Chandrabose | Director | 29-May-1998 | Current |
Financial Performance of Aurobindo Biotech Products.
Aurobindo Biotech Products Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 15.87% increase in profit. The company's net worth dipped by a decrease of 0.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aurobindo Biotech Products?
In 2023, Aurobindo Biotech Products had a promoter holding of 93.00% and a public holding of 7.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bose Building Materials & Prefab Houses Private LimitedActive 10 years 10 monthsMancham Chandrabose and Sreeram Manchem are mutual person
Extraco Composites India Private LimitedActive 18 years 4 monthsMancham Chandrabose and Sreeram Manchem are mutual person
- Enpro Industrial Automation Private LimitedActive 35 years 5 months
Sreeram Manchem is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 21 Mar 2007 | ₹12.10 Cr | Open |
How Many Employees Work at Aurobindo Biotech Products?
Unlock and access historical data on people associated with Aurobindo Biotech Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurobindo Biotech Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurobindo Biotech Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
